Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date.

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may increase patients’ risk for a dangerous eye condition. At such a critical moment ...

Although only association and not causality can be inferred, this study showed that, among patients who had diabetes, an elevated risk of NAION was associated with semaglutide use compared with ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Increase in NAION associated with semaglutide use among individuals with type 2 diabetes. (HealthDay News) — For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly ...

26, 2025 (HealthDay News) -- For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased ...

Considering taking supplements to treat ischemic optic neuropathy? Below is a list of common natural remedies used to treat or reduce the symptoms of ischemic optic neuropathy. Follow the links to ...

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and ...

The possibility that astrocyte-axon interactions are important in the development of glaucomatous optic neuropathy suggests new avenues of therapeutic intervention, not related to the control of ...